The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
The soluble interleukin 6 receptor: mechanisms of production and implications in disease
Abstract
Interleukin 6 (IL‐6) performs a prominent role during disease and has been described as both a pro‐ and anti‐inflammatory cytokine. A key feature in the regulation of IL‐6 responses has been the identification of a soluble interleukin 6 receptor (sIL‐6R), which forms a ligand‐receptor complex with IL‐6 that is capable of stimulating a variety of cellular responses including proliferation, differentiation and activation of inflammatory processes. Elevated sIL‐6R levels have been documented in numerous clinical conditions indicating that its production is coordinated as part of a disease response. Thus, sIL‐6R has the potential to regulate both local and systemic IL‐6‐mediated events. This review will outline the central role of sIL‐6R in the coordination of IL‐6 responses. Details relating to the mechanisms of sIL‐6R production will be provided, while the potential significance of sIL‐6R during the development of clinical conditions will be emphasized. We want to convey, therefore, that when thinking about the inflammatory capability of IL‐6, it is essential to consider not only the action of IL‐6 itself, but also the effect sIL‐6R may have on cellular processes.—Jones, S. A., Horiuchi, S., Topley, M. Yamamoto, N., Fuller, G. M. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15, 43–58 (2001)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.1 · Cited by 2,069
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
An Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
Moss, M. L., Jin, S.-L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W.-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., et al. (1997) · Nature · doi:10.1038/385733a0 · Cited by 1,378
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Pepys, M. B., & Baltz, M. L. (1983) · Advances in Immunology · doi:10.1016/s0065-2776(08)60379-x · Cited by 1,272
Interleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., & Kishimoto, T. (1988) · Science · doi:10.1126/science.3136546 · Cited by 1,060
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012
Stahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. E., & Yancopoulos, G. D. (1995) · Science · doi:10.1126/science.7871433 · Cited by 979
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
Tilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Lütticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., et al. (1994) · Science · doi:10.1126/science.8272872 · Cited by 814
Increased plasma levels of interleukin-6 in sepsis [see comments]
Hack, C., De Groot, E., Felt-Bersma, R., Nuijens, J., Strack Van Schijndel, R., Eerenberg-Belmer, A., Thijs, L., & Aarden, L. (1989) · Blood · doi:10.1182/blood.v74.5.1704.1704 · Cited by 811
Soluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
IL-6-Induced Homodimerization of gp130 and Associated Activation of a Tyrosine Kinase
Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T., & Kishimoto, T. (1993) · Science · doi:10.1126/science.8511589 · Cited by 724
Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.407 · Cited by 635
LIFRβ and gp130 as Heterodimerizing Signal Transducers of the Tripartite CNTF Receptor
Davis, S., Aldrich, T. H., Stahl, N., Pan, L., Taga, T., Kishimoto, T., Ip, N. Y., & Yancopoulos, G. D. (1993) · Science · doi:10.1126/science.8390097 · Cited by 634
Interleukin 6 is required for the development of collagen-induced arthritis
Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, V., & Ciliberto, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.461 · Cited by 604
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Kerwar, S. S., Torranee, D. S., Otten-Evans, C., Greenstreet, T., Weerawarna, K., et al. (1994) · Nature · doi:10.1038/370218a0 · Cited by 588
Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2207 · Cited by 578
Disruption of the CNTF gene results in motor neuron degeneration
Masu, Y., Wolf, E., Holtmann, B., Sendtner, M., Brem, G., & Thoenen, H. (1993) · Nature · doi:10.1038/365027a0 · Cited by 558
Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy.
Pennica, D., King, K. L., Shaw, K. J., Luis, E., Rullamas, J., Luoh, S. M., Darbonne, W. C., Knutzon, D. S., Yen, R., & Chien, K. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1142 · Cited by 554
Kotake, S., Sato, K., Kim, K. J., Takahashi, N., Udagawa, N., Nakamura, I., Yamaguchi, A., Kishimoto, T., Suda, T., & Kashiwazaki, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110113 · Cited by 545
Guerne, P. A., Zuraw, B. L., Vaughan, J. H., Carson, D. A., & Lotz, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113921 · Cited by 513
Poli, G., Bressler, P., Kinter, A., Duh, E., Timmer, W. C., Rabson, A., Justement, J. S., Stanley, S., & Fauci, A. S. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.151 · Cited by 512
The soluble interleukin‐6 receptor is generated by shedding
Mülberg, J., Schooltink, H., Stoyan, T., Günther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230226 · Cited by 506
Hirota, H., Yoshida, K., Kishimoto, T., & Taga, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4862 · Cited by 505
Soluble cytokine receptors are present in normal human urine.
Novick, D., Engelmann, H., Wallach, D., & Rubinstein, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1409 · Cited by 434
Pennica, D., Shaw, K. J., Swanson, T. A., Moore, M. W., Shelton, D. L., Zioncheck, K. A., Rosenthal, A., Taga, T., Paoni, N. F., & Wood, W. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10915 · Cited by 429
IL-6 is required for the development of Th1 cell-mediated murine colitis
Yamamoto, M., Yoshizaki, K., Kishimoto, T., & Ito, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4878 · Cited by 411
Udagawa, N., Takahashi, N., Katagiri, T., Tamura, T., Wada, S., Findlay, D. M., Martin, T. J., Hirota, H., Taga, T., Kishimoto, T., et al. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1461 · Cited by 409
Involvement of IL-6 in mesangial proliferative glomerulonephritis.
Horii, Y., Muraguchi, A., Iwano, M., Matsuda, T., Hirayama, T., Yamada, H., Fujii, Y., Dohi, K., Ishikawa, H., Ohmoto, Y., et al. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.12.3949 · Cited by 408
Interleukin 6 plays a key role in the development of antigen-induced arthritis
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
Ogata, A., Chauhan, D., Teoh, G., Treon, S. P., Urashima, M., Schlossman, R. L., & Anderson, K. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.5.2212 · Cited by 399
Arribas, J., Coodly, L., Vollmer, P., Kishimoto, T. K., Rose-John, S., & Massagué, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11376 · Cited by 391
The Major Receptor for C-Reactive Protein on Leukocytes Is Fcγ Receptor II
Bharadwaj, D., Stein, M.-P., Volzer, M., Mold, C., & Clos, T. W. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.4.585 · Cited by 391
Maes, M., Lin, A.-H., Delmeire, L., Van Gastel, A., Kenis, G., De Jongh, R., & Bosmans, E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00131-0 · Cited by 387
Maes, M., Bosmans, E., Calabrese, J., Smith, R., & Meltzer, H. Y. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)00049-w · Cited by 385
Coeshott, C., Ohnemus, C., Pilyavskaya, A., Ross, S., Wieczorek, M., Kroona, H., Leimer, A. H., & Cheronis, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6261 · Cited by 365
Escary, J.-L., Perreau, J., Duménil, D., Ezine, S., & Brûlet, P. (1993) · Nature · doi:10.1038/363361a0 · Cited by 364
Boulton, T. G., Stahl, N., & Yancopoulos, G. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78174-5 · Cited by 361
de Benedetti, F., Massa, M., Robbioni, P., Ravelli, A., Burgio, G. R., & Martini, A. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340912 · Cited by 358
Released Form of CNTF Receptor α Component as a Soluble Mediator of CNTF Responses
Davis, S., Aldrich, T. H., Ip, N. Y., Stahl, N., Scherer, S., Farruggella, T., DiStefano, P. S., Curtis, R., Panayotatos, N., Gascan, H., et al. (1993) · Science · doi:10.1126/science.7681218 · Cited by 350
Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G., Taga, T., & Kishimoto, T. (1993) · Blood · doi:10.1182/blood.v82.4.1120.1120 · Cited by 343
Sympathetic neurons can produce and respond to interleukin 6
März, P., Cheng, J.-G., Gadient, R. A., Patterson, P. H., Stoyan, T., Otten, U., & Rose-John, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3251 · Cited by 332
Human soluble IL-6 receptor: its detection and enhanced release by HIV infection
Honda, M., Yamamoto, S., Cheng, M., Yasukawa, K., Suzuki, H., Saito, T., Osugi, Y., Tokunaga, T., & Kishimoto, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2175 · Cited by 331
Hirota, H., Kiyama, H., Kishimoto, T., & Taga, T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2627 · Cited by 321
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 316
Gerhartz, C., Heesel, B., Sasse, J., Hemmann, U., Landgraf, C., Schneider-Mergener, J., Horn, F., Heinrich, P. C., & Graeve, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12991 · Cited by 307
Saito, M., Yoshida, K., Hibi, M., Taga, T., & Kishimoto, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.12.4066 · Cited by 282
Interleukin-6 and Soluble Interleukin-6 Receptor: Direct Stimulation of gp130 and Hematopoiesis
Peters, M., Müller, A. M., & Rose-John, S. (1998) · Blood · doi:10.1182/blood.v92.10.3495 · Cited by 276
Peters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer zum Büschenfelde, K. H., & Rose-John, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1399 · Cited by 276
Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.
Wendling, D., Racadot, E., & Wijdenes, J. (1993) · PubMed · Cited by 274
Neutrophil rolling altered by inhibition of L-selectin shedding in vitro
Walcheck, B., Kahn, J., Fisher, J. M., Wang, B. B., Fisk, R. S., Payan, D. G., Feehan, C., Betageri, R., Darlak, K., Spatola, A. F., et al. (1996) · Nature · doi:10.1038/380720a0 · Cited by 273
Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis
Takagi, N., Mihara, M., Moriya, Y., Nishimoto, N., Yoshizaki, K., Kishimoto, T., Takeda, Y., & Ohsugi, Y. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2117::aid-art6>3.0.co;2-p · Cited by 270
The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.
Müllberg, J., Oberthür, W., Lottspeich, F., Mehl, E., Dittrich, E., Graeve, L., Heinrich, P. C., & Rose-John, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.4958 · Cited by 269
Interleukin-6 prevents dexamethasone-induced myeloma cell death
Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Xiao, H., & Epstein, J. (1994) · Blood · doi:10.1182/blood.v84.9.3063.3063 · Cited by 262
Novel neurotrophin-1/B cell-stimulating factor-3: A cytokine of the IL-6 family
Senaldi, G., Varnum, B. C., Sarmiento, U., Starnes, C., Lile, J., Scully, S., Guo, J., Elliott, G., McNinch, J., Shaklee, C. L., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11458 · Cited by 251
A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor
Müllberg, J., Durie, F. H., Otten-Evans, C., Alderson, M. R., Rose-John, S., Cosman, D., Black, R. A., & Mohler, K. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.11.5198 · Cited by 249
Van Wagoner, N. J., Oh, J.-W., Repovic, P., & Benveniste, E. N. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05236.1999 · Cited by 244
Ulich, T. R., Yin, S., Guo, K., Yi, E. S., Remick, D. G., & del Castillo, J. M. G. (1991) · PubMed Central · Cited by 241
Crowe, P. D., Walter, B. N., Mohler, K. M., Otten-Evans, C., Black, R. A., & Ware, C. F. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1205 · Cited by 231
Modur, V, Li, Y., Zimmerman, G. A., Prescott, S. M., & McIntyre, T. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119821 · Cited by 204
Romas, E., Udagawa, N., Zhou, H., Tamura, T., Saito, M., Taga, T., Hilton, D. J., Suda, T., Ng, K. W., & Martin, T. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2581 · Cited by 202
Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model
Barton, B. E., & Jackson, J. V. (1993) · Infection and Immunity · doi:10.1128/iai.61.4.1496-1499.1993 · Cited by 200
Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6.
Baumann, H., & Schendel, P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54940-1 · Cited by 199
Taga, T., Narazaki, M., Yasukawa, K., Saito, T., Miki, D., Hamaguchi, M., Davis, S., Shoyab, M., Yancopoulos, G. D., & Kishimoto, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10998 · Cited by 198
MIHARA, M., MORIYA, Y., KISHIMOTO, T., & OHSUGI, Y. (1995) · Rheumatology · doi:10.1093/rheumatology/34.4.321 · Cited by 198
Horiuchi, S., Koyanagiu, Y., Zhouu, Y., Miyamotou, H., Tanakau, Y., Waki, M., Matsumoto, A., Yamamotou, M., & Yamamotof, N. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240837 · Cited by 197
Self-citationRosendahl, M. S., Ko, S. C., Long, D. L., Brewer, M. T., Rosenzweig, B., Hedl, E., Anderson, L., Pyle, S. M., Moreland, J., Meyers, M. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24588 · Cited by 197
Gaillard, J., Bataille, R., Brailly, H., Zuber, C., Yasukawa, K., Attal, M., Maruo, N., Taga, T., Kishimoto, T., & Klein, B. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230408 · Cited by 196
C-reactive Protein: A Physiological Activator of Interleukin 6 Receptor Shedding
Jones, S. A., Novick, D., Horiuchi, S., Yamamoto, N., Szalai, A. J., & Fuller, G. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.599 · Cited by 196
Self-citationMitsuyama, K., Toyonaga, A., Sasaki, E., Ishida, O., Ikeda, H., Tsuruta, O., Harada, K., Tateishi, H., Nishiyama, T., & Tanikawa, K. (1995) · Gut · doi:10.1136/gut.36.1.45 · Cited by 186
Gearing, D. P., & Cosman, D. (1991) · Cell · doi:10.1016/0092-8674(91)90131-h · Cited by 181
Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6
Guillen, I., Blanes, M., Gomez-Lechon, M. J., & Castell, J. V. (1995) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1995.269.2.r229 · Cited by 179
Klouche, M., Bhakdi, S., Hemmes, M., & Rose-John, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4583 · Cited by 178
Peters, M., Schirmacher, P., Goldschmitt, J., Odenthal, M., Peschel, C., Fattori, E., Ciliberto, G., Dienes, H.-P., Büschenfelde, K.-H. M. Z., & Rose-John, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.755 · Cited by 170
Cytokine regulation of CC and CXC chemokine expression by human astrocytes
Oh, J.-W., Schwiebert, L. M., & Benveniste, E. N. (1999) · Journal of Neurovirology · doi:10.3109/13550289909029749 · Cited by 169
Proteolytic Cleavage of ICAM-1 by Human Neutrophil Elastase
Champagne, B., Tremblay, P., Cantin, A., & St. Pierre, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6398 · Cited by 167
Salvi, M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2976 · Cited by 165
Soluble IL-6 Receptor Potentiates the Antagonistic Activity of Soluble gp130 on IL-6 Responses
Müller-Newen, G., Küster, A., Hemmann, U., Keul, R., Horsten, U., Martens, A., Graeve, L., Wijdenes, J., & Heinrich, P. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6347 · Cited by 162
Szekanecz, Z., Shah, M. R., Pearce, W. H., & Koch, A. E. (1994) · Inflammation Research · doi:10.1007/bf01983484 · Cited by 161
Robak, T., Gladalska, A., Stepień, H., & Robak, E. (1998) · Mediators of Inflammation · doi:10.1080/09629359890875 · Cited by 161
Ernst, M., Gearing, D. P., & Dunn, A. R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06420.x · Cited by 160
Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo.
Schöbitz, B., Pezeshki, G., Pohl, T., Hemmann, U., Heinrich, P. C., Holsboer, F., & Reul, J. M. H. M. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768358 · Cited by 159
Interleukin-6 is a prognostic factor in multiple myeloma [letter] [see comments]
Ludwig, H., Nachbaur, D., Fritz, E., Krainer, M., & Huber, H. (1991) · Blood · doi:10.1182/blood.v77.12.2794.2794 · Cited by 158 · cited 1×
“Indeed, levels of IL-6 are significantly elevated in patients suffering from this condition (148).”
BackgroundMatsuda, T., Takahashi-Tezuka, M., Fukada, T., Okuyama, Y., Fujitani, Y., Tsukada, S., Mano, H., Hirai, H., Witte, O. N., & Hirano, T. (1995) · Blood · doi:10.1182/blood.v85.3.627.bloodjournal853627 · Cited by 155
Ganapathi, M. K., May, L. T., Schultz, D. A., Brabenec, A., Weinstein, J. A., Sehgal, P. B., & Kushner, I. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80043-3 · Cited by 154
Zouki, C., Beauchamp, M., Baron, C., & Filep, J. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119561 · Cited by 152
Sui, X., Tsuji, K., Tanaka, R., Tajima, S., Muraoka, K., Ebihara, Y., Ikebuchi, K., Yasukawa, K., Taga, T., & Kishimoto, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2859 · Cited by 148
Matsuda, T., Fukada, T., Takahashi-Tezuka, M., Okuyama, Y., Fujitani, Y., Hanazono, Y., Hirai, H., & Hirano, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11037 · Cited by 142
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges, A., Gabay, C., Silacci, P., Novick, D., Roux-Lombard, P., Grau, G. E., Dayer, J. M., VISCHER, T. L., & Guerne, P. A. (1997) · PubMed · Cited by 134
INTERLEUKIN 6 KNOCK-OUT MICE ARE RESISTANT TO ANTIGEN-INDUCED EXPERIMENTAL ARTHRITIS
Boe, A., Baiocchi, M., Carbonatto, M., Papoian, R., & Serlupi‐Crescenzi, O. (1999) · Cytokine · doi:10.1006/cyto.1999.0502 · Cited by 132
Maione, D., Carlo, E. D., Li, W., Musiani, P., Modesti, A., Peters, M., Rose‐John, S., Rocca, C. D., Tripodi, M., Lazzaro, D., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5588 · Cited by 128
Le-Barillec, K., Si‐Tahar, M., Balloy, V., & Chignard, M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5779 · Cited by 124
Leukemia inhibitory factor, a cytokine at the interface between neurobiology and immunology.
Patterson, P. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.7833 · Cited by 120
Differential shedding of the two subunits of the interleukin‐6 receptor
Müllberg, J., Dittrich, E., Graeve, L., Gerhartz, C., Yasukawa, K., Taga, T., Kishimoto, T., Heinrich, P. C., & Rose‐John, S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80507-q · Cited by 118
Silacci, P., Dayer, J., Desgeorges, A., Peter, R. E., Manueddu, C., & Guerne, P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13625 · Cited by 118
Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor
Müllberg, J., Schooltink, H., Stoyan, T., Heinrich, P. C., & Rose‐John, S. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92272-y · Cited by 118
Tajima, S., Tsuji, K., Ebihara, Y., Sui, X., Tanaka, R., Muraoka, K., Yoshida, M., Yamada, K., Yasukawa, K., Taga, T., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.4.1357 · Cited by 115
Takayanagi, H., Juji, T., Miyazaki, T., Iizuka, H., Takahashi, T., Isshiki, M., Okada, M., Tanaka, Y., Koshihara, Y., Oda, H., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6093 · Cited by 107
Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide.
Walev, I., Vollmer, P., Palmer, M., Bhakdi, S., & Rose‐John, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7882 · Cited by 102
Role of IL-6 and the Soluble IL-6 Receptor in Inhibition of VCAM-1 Gene Expression
Oh, J., Wagoner, N. J. V., Rose‐John, S., & Benveniste, E. N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4992 · Cited by 102
Bennett, T. A., Lynam, E. B., Sklar, L. A., & Rogelj, S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3093 · Cited by 102
Hasegawa, M. (1999) · British journal of rheumatology · doi:10.1093/rheumatology/38.7.612 · Cited by 100
Keul, R., Heinrich, P. C., Müller-Newen, G., Muller, K., & Woo, P. (1998) · Cytokine · doi:10.1006/cyto.1997.0343 · Cited by 98
Vollmer, P., Walev, I., Rose‐John, S., & Bhakdi, S. (1996) · Infection and Immunity · doi:10.1128/iai.64.9.3646-3651.1996 · Cited by 98
Dempsey, P. J., Meise, K. S., Yoshitake, Y., Nishikawa, K., & Coffey, R. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.747 · Cited by 92
Bank, U., Reinhold, D., Schneemilch, C. E., Kunz, D., Synowitz, H., & Ansorge, S. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099312957 · Cited by 90
Hargreaves, P. G., Wang, F., Antcliff, J. F., Murphy, G., Lawry, J., Russell, R. G. G., & Croucher, P. I. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00754.x · Cited by 89
BARBER, M. D., Fearon, K. C. H., & Ross, J. A. (1999) · Clinical Science · doi:10.1042/cs0960083 · Cited by 89
Padberg, F., Feneberg, W. W., Schmidt, S., Schwarz, M., Körschenhausen, D. A., Greenberg, B. D., Nolde, T., Müller, N., Trapmann, H., König, N., et al. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00120-4 · Cited by 88
Soluble interleukin‐6 receptor as a prognostic factor in multiple myeloma
Pulkki, K., Pelliniemi, T., Rajamäki, A., Tienhaara, A., Laakso, M., & Lahtinen, R. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1470.x · Cited by 88
Schirmacher, P., Peters, M., Ciliberto, G., Blessing, M., Lotz, J., Büschenfelde, K. M. Z., & Rose‐John, S. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65605-2 · Cited by 87
Kumar, G., Gupta, S., Wang, S., & Nel, A. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4436 · Cited by 80
Rr, K., Tm, H., & Webster, R. O. (1990) · PubMed · Cited by 80
Diamant, M., Rieneck, K., Mechti, N., Zhang, X., Svenson, M., Bendtzen, K., & Klein, B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00750-3 · Cited by 79
Soluble interleukin‐6 receptor (sIL‐6R), a new prognostic factor in multiple myeloma
Kyrtsonis, M., Dedoussis, G. V., Zervas, C., Perifanis, V., Baxevanis, C. N., Stamatelou, M., & Maniatis, A. G. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.4721018.x · Cited by 79
Franchimont, N., Rydziel, S., Delany, A. M., & CANALIS, E. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12144 · Cited by 78
März, P., Heese, K., Höck, C., Golombowski, S., Müller-Spahn, F., Rose‐John, S., & Otten, U. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00886-0 · Cited by 74
Circulating Interleukin-6 Receptor in Patients with Sepsis Syndrome
Frieling, J. T. M., van Deuren, M., Wijdenes, J., van der Meer, J. W. M., Clement, C., van der Linden, J., & Sauerwein, R. W. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.469 · Cited by 72
Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma
Hans, V., Kossmann, T., Joller, H., Otto, V. I., & Morganti-Kossmann, M. C. (1999) · Neuroreport · doi:10.1097/00001756-199902050-00036 · Cited by 71
Müller‐Newen, G., Köhne, C., Keul, R., Hemmann, U., Müller‐Esterl, W., Wijdenes, J., Brakenhoff, J. P. J., Hart, M. H. L., & Heinrich, P. C. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00837.x · Cited by 70
Neddermann, P., Graziani, R., Ciliberto, G., & Paonessa, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30986 · Cited by 65
Jones, S. A., Horiuchi, S., Novick, D., Yamamoto, N., & Fuller, G. M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11<3514::aid-immu3514>3.0.co;2-t · Cited by 64
Self-citationIs IL-6 both a cytokine and a neurotrophic factor?
Wagner, J. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2417 · Cited by 63
A gp130 Interleukin-6 Transducer-Dependent SCID Model of Human Multiple Myeloma
Rebouissou, C., Wijdenes, J., Autissier, P., Tarte, K., Costes, V., Liautard, J., Rossi, J., Brochier, J., & Klein, B. (1998) · Blood · doi:10.1182/blood.v91.12.4727 · Cited by 63
Stübner, S., Schön, T., Padberg, F., Teipel, S. J., Schwarz, M. J., Haslinger, A., Buch, K., Dukoff, R., Lasser, R., Müller, N., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00916-1 · Cited by 59
Circulating Levels of Soluble Interleukin-6 Receptor in Patients with Bronchial Asthma
Yokoyama, A., Kohno, N., Sakai, K., KONDO, K.-I., Hirasawa, Y., & Hiwada, K. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.5.9610070 · Cited by 59
Coeshott, C. M., Pilyavskaya, A., Ross, S., Wieczorek, M., Kroona, H., Leimer, A. H., & Cheronis, J. C. (1999) · Cited by 57
Guerne, P., Desgeorges, A., Jaspar, J.-M., Relić, B., Peter, R. E., Hoffmeyer, P. J., & Dayer, J. (1999) · Matrix Biology · doi:10.1016/s0945-053x(99)00021-9 · Cited by 55
Pflanz, S., Tacken, I., Grötzinger, J., Jacques, Y., Dahmen, H., Heinrich, P. C., & Müller‐Newen, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00477-9 · Cited by 55
Gaillard, J., Liautard, J., Klein, B., & Brochier, J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271232 · Cited by 55
Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease
Hampel, H. J., Sunderland, T., Kötter, H. U., Schneider, C., Teipel, S. J., Padberg, F., Dukoff, R. A., Levy, J., & Möller, H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01355-3 · Cited by 52
Jakobsen, P., McKay, V., Morris-Jones, S. D., McGuire, W. L., van Hensbroek, M. B., Meisner, S., Bendtzen, K., Schousboe, I., Bygbjerg, I. C., & Greenwood, B. M. (1994) · Infection and Immunity · doi:10.1128/iai.62.10.4374-4379.1994 · Cited by 51
Hermann, E., Fleischer, B., Mayet, W.-J., Poralla, T., & Büschenfelde, K. ‐. M. Z. (1989) · PubMed · Cited by 50
Murakami-Mori, K., Taga, T., Kishimoto, T., & Nakamura, S. (1996) · International Immunology · doi:10.1093/intimm/8.4.595 · Cited by 50
Matsuda, T., & Hirano, T. (1994) · Blood · doi:10.1182/blood.v83.12.3457.3457 · Cited by 50
Peters, M. J., Odenthal, M., Schirmacher, P., Blessing, M., Fattori, E., Ciliberto, G., Büschenfelde, K. H. M. Z., & Rose‐John, S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1474 · Cited by 48
Sui, X., Tsuji, K., Ebihara, Y., Tanaka, R., Muraoka, K., Yoshida, M., Yamada, K., Yasukawa, K., Taga, T., Kishimoto, T., et al. (1999) · Blood · doi:10.1182/blood.v93.8.2525 · Cited by 47
Özbek, S., Grötzinger, J., Krebs, B., Fischer, M., Wollmer, A., Jostock, T., Müllberg, J., & Rose‐John, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21374 · Cited by 42
Montero‐Julian, F. A., Brailly, H., Sautès‐Fridman, C., Joyeux, I., Dorval, T., Mosseri, V., Yasukawa, K., Wijdenes, J., Adler, A., Gorin, I., et al. (1997) · PubMed · Cited by 40
Ohtani, K., Ninomiya, H., Hasegawa, Y., Kobayashi, T., Kojima, H., Nagasawa, T., & Abe, T. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05255.x · Cited by 37
Oh, J. (1996) · Cytokine · doi:10.1006/cyto.1996.0055 · Cited by 35
HORIUCHI, AMPOFO, Koyanagi, Yamashita, Waki, MATSUMOTO, YAMAMOTO, & YAMAMOTO (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00622.x · Cited by 34
Yokoyama, A., Kohno, N., Hirasawa, Y., KONDO, K., Abe, M., Inoue, Y., Fujioka, S., Fujino, S., ISHIDA, S., & Hiwada, K. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03672.x · Cited by 32
Dowben, R. M., Gaffey, A., & Lynch, P. M. (1968) · FEBS Letters · doi:10.1016/0014-5793(68)80083-3 · Cited by 31
Riet, I. V., Greef, C. D., Aharchi, F., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400564 · Cited by 29
Mackiewicz, A., Rose‐John, S., Schooltink, H., Łaciak, M., Górny, A., & Heinrich, P. C. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81012-b · Cited by 29
Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor
Vollmer, P., Peters, M., Ehlers, M., Yagame, H., Matsuba, T., Kondo, M., Yasukawa, K., Büschenfelde, K. M. Z., & Rose‐John, S. (1996) · Journal of Immunological Methods · doi:10.1016/s0022-1759(96)00163-9 · Cited by 29
Thabard, W., Barillé‐Nion, S., Collette, M., Harousseau, J., Rapp, M.-J., Bataille, R., & Amiot, M. (1999) · PubMed · Cited by 28
Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130)
Geisterfer, M., Richards, C. D., & Gauldie, J. (1995) · Cytokine · doi:10.1006/cyto.1995.0068 · Cited by 27
Cardiotrophin‐1 Induces the Same Neuropeptides in Sympathetic Neurons as Do Neuropoietic Cytokines
Cheng, J., Pennica, D., & Patterson, P. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062278.x · Cited by 27
Schroder, W., Gaetje, R., & Baumann, R. (1996) · PubMed · Cited by 26
Haggiag, S., Chebath, J., & Revel, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01040-6 · Cited by 26
Interleukin 6 and its soluble receptor are elevated in aqueous humor of patients with uveitis
Petrinović-Dorešič, J., Mažuran, R., Henč-Petrinović, L., Kuzmanović, B., & Jovičić, A. (1999) · Ocular Immunology and Inflammation · doi:10.1076/ocii.7.2.75.4017 · Cited by 26
Modrell, B., Liu, J., Miller, H., & SHOYAB, M. (1994) · Growth Factors · doi:10.3109/08977199409001050 · Cited by 24
Kyriakou (1997) · International Journal of Hematology · doi:10.1016/s0925-5710(97)00055-8 · Cited by 22
Cichy, J., Rose‐John, S., Potempa, J., Pryjma, J. R., & Travis, J. W. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5648 · Cited by 21
Matsumura, M., Banba, N., Motohashi, S., & Hattori, Y. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00368-9 · Cited by 21
Jabłońska, E. (1998) · Cytokine · doi:10.1006/cyto.1997.0327 · Cited by 14
Zhou, Y., Horiuchi, S., Yamamoto, M., & Yamamoto, N. (1998) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1998.tb02258.x · Cited by 8
Self-citation
Cited by
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Self-citationMuscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388
Cytokine storm and sepsis disease pathogenesis
Chousterman, B. G., Swirski, F. K., & Weber, G. F. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0639-8 · Cited by 1,330
(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146
Metadata
- Authors
- JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., & FULLER, G. M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-01
- Volume
- 15
- Issue
- 1
- Pages
- 43-58
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1968643760
- Cited by
- 623
- References
- 172
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.